This topic contains a solution. Click here to go to the answer

Author Question: A person is prescribed sertraline (Zoloft) 100 mg PO daily. Which change in sleep is likely ... (Read 33 times)

altibaby

  • Hero Member
  • *****
  • Posts: 562
A person is prescribed sertraline (Zoloft) 100 mg PO daily. Which change in sleep is likely secondary to this medication? The patient will have:
 
  a. more dreams.
  b. excessive sleepiness.
  c. less slow-wave sleep.
  d. less rapid eye movement (REM) sleep.

Question 2

A patient needs diagnostic evaluation of sleep problems. Which test will evaluate the patient for possible sleep-related problems?
 
  a. Skull x-rays
  b. Electroencephalogra m (EEG)
  c. Positron emission tomography (PET)
  d. Single-photon emission computed tomography (SPECT)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

snackralk

  • Sr. Member
  • ****
  • Posts: 363
Answer to Question 1

ANS: D
Sertraline (Zoloft) is an SSRI antidepressant medication, which suppresses REM sleep. Dreams would decrease because they occur during REM. Benzodiazepines reduce slow-wave sleep. SSRIs have a side effect of insomnia.

Answer to Question 2

ANS: B
Electroencephalogra m (EEG) measures NREM and REM sleep. The distracters represent ways to diagnose structural and metabolic problems.




altibaby

  • Member
  • Posts: 562
Reply 2 on: Jul 19, 2018
Gracias!


6ana001

  • Member
  • Posts: 311
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library